Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 94.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.50% |
| Dec 31, 2024 | -28.99% |
| Sep 30, 2024 | -56.17% |
| Jun 30, 2024 | 86.43% |
| Mar 31, 2024 | 69.35% |
| Sep 30, 2023 | -110.08% |
| Mar 31, 2023 | -225.46% |
| Sep 30, 2022 | -26.54% |
| Dec 31, 2021 | -26.05% |
| Sep 30, 2021 | -26.18% |
| Jun 30, 2021 | 6.88% |
| Mar 31, 2021 | 39.91% |
| Sep 30, 2020 | -594.87% |
| Mar 31, 2020 | 434.68% |
| Dec 31, 2019 | 277.94% |
| Sep 30, 2019 | 31.91% |
| Jun 30, 2019 | -140.59% |
| Mar 31, 2019 | 444.42% |
| Dec 31, 2018 | 554.36% |
| Sep 30, 2018 | 456.75% |
| Jun 30, 2018 | -446.64% |
| Mar 31, 2018 | -802.89% |
| Dec 31, 2017 | 106.44% |
| Sep 30, 2017 | -58.50% |
| Jun 30, 2017 | 94.39% |
| Mar 31, 2017 | -26.54% |
| Dec 31, 2016 | 27.78% |
| Sep 30, 2016 | 36.15% |
| Jun 30, 2016 | -25.60% |
| Mar 31, 2016 | -26.91% |
| Dec 31, 2015 | 26.07% |
| Sep 30, 2015 | -3,441.49% |
| Jun 30, 2015 | 162.87% |
| Mar 31, 2015 | -105.57% |
| Dec 31, 2014 | -26.09% |
| Sep 30, 2014 | 111.48% |